Request Free Sample
×
France Ascites Market
ID: MRFR/HC/54590-HCR
200 Pages
June 2025
France Ascites Market Research Report: By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries) andBy End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers)- Forecast to 2035
Industry Developments
The France Ascites Market has witnessed notable developments recently. In September 2023, Roche launched a new treatment specifically addressing ascites associated with liver cancer, marking a significant advancement in therapeutic options available for patients. Meanwhile, Pfizer and AbbVie have been ramping up their Research and Development efforts to explore innovative therapies targeting ascites, highlighting the ongoing commitment to enhancing patient care in this domain. Current affairs indicate a rising prevalence of liver disease in France, prompting heightened focus on ascites management and treatment solutions. Merck has notably strengthened its market position by acquiring a biotechnology firm specializing in liver diseases in August 2023, thereby expanding its product pipeline. Moreover, Fresenius Kabi announced an increase in its investment in ascitic fluid management solutions, aiming to enhance quality of care. Overall, the market dynamics are influenced by the growing prevalence of ascites-linked diseases, advancements in drug development, and mergers that are reshaping the competitive landscape, reflecting a commitment by companies such as Bristol Myers Squibb, Amgen, and Eisai to improve treatment modalities in France.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 38.7(USD Million) |
| MARKET SIZE 2024 | 40.8(USD Million) |
| MARKET SIZE 2035 | 85.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.9% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Pfizer, Merck, AbbVie, Genentech, Fresenius Kabi, Eisai, Roche, BristolMyers Squibb, Amgen, Terumo Corporation, Zymeworks, Baxter International, Sobi, Mallinckrodt Pharmaceuticals, B. Braun Melsungen |
| SEGMENTS COVERED | Type, Diagnosis, Treatment, End User |
| KEY MARKET OPPORTUNITIES | Increase in liver disease prevalence, Advancements in treatment modalities, Growing demand for diagnostic tools, Rising awareness and education, Expanding healthcare infrastructure investment |
| KEY MARKET DYNAMICS | increasing prevalence of liver diseases, rising healthcare expenditure, advancement in diagnostic technologies, growing awareness of treatment options, strong pipeline of therapeutic drugs |
| COUNTRIES COVERED | France |
FAQs
What is the expected market size of the France Ascites Market by 2024?
The France Ascites Market is expected to be valued at approximately 40.8 million USD by the year 2024.
What will be the market size of the France Ascites Market by 2035?
By 2035, the France Ascites Market is projected to reach around 85.0 million USD.
What is the expected compound annual growth rate (CAGR) for the France Ascites Market from 2025 to 2035?
The expected CAGR for the France Ascites Market from 2025 to 2035 is 6.9%.
Which segment of the France Ascites Market is expected to dominate in terms of market value by 2035?
By 2035, the Transudative Ascites segment is expected to dominate with a market value of approximately 51.0 million USD.
What was the market value of the Exudate Ascites segment in 2024?
In 2024, the Exudate Ascites segment was valued at around 16.0 million USD.
Who are the key players in the France Ascites Market?
Major players in the France Ascites Market include Pfizer, Merck, AbbVie, Genentech, and Roche among others.
What is the expected market value for the Transudative Ascites segment by 2024?
The market value for the Transudative Ascites segment is expected to be approximately 24.8 million USD by 2024.
What challenges might impact the France Ascites Market growth?
Challenges such as regulatory hurdles and competition among established players could affect market growth.
What opportunities exist for growth in the France Ascites Market?
Opportunities for growth include the development of innovative treatments and an increasing patient population.
How is the overall growth rate of the France Ascites Market compared to previous years?
The growth rate from 2025 to 2035 shows a positive trend, indicating a stable increase compared to prior years.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment